Nadunolimab Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1/2: 2

Top Sponsors

M.D. Anderson Cancer Center1
Dan Feng1

Indications

Cancer2
Acute Myelogenous Leukemia (AML)1
Myelodysplastic Syndrome(MDS)1
Metastatic Microsatellite Stable Colorectal Carcinoma1

New York, New York1 trial

Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC

Icahn School of Medicine at Mount Sinai

Phase 1/2

Houston, Texas1 trial

A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

MD Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.